REPRISE China - Clinical Evaluation in China

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Stenoses, Aortic Valve
Interventions
DEVICE

Lotus Edge™ Valve System

"• The Lotus Edge™ Valve System consisting of two main components:~* a bioprosthetic bovine pericardial aortic valve, and~* a delivery system Device sizes include 23 mm, 25 mm and 27 mm diameter."

Trial Locations (1)

Unknown

Cardiovascular Institute and Fu Wai Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY